Latest News

Date Title Topic
18 Apr 2014 Does a More Refined Categorisation of Tumour Response and/or Progression Improve Prediction of Overall Survival in RECIST 1.1? Anticancer agents & Biologic therapy
17 Apr 2014 ESMO is Hiring
17 Apr 2014 European Medicines Agency and EU National Competent Authorities Agree on Action Plan to Address Medication Errors Bioethics, legal and economic issues
16 Apr 2014 ESMO E-Learning: 2013 Highlights in NSCLC
16 Apr 2014 In-depth Focus on Effective Cancer Control and Care in China, India, and Russia Cancer prevention
15 Apr 2014 A Meta-Analysis of First Generation EGFR TKIs vs. Chemotherapy in Patients with Wild Type EGFR Non-Small Cell Lung Cancer Lung and other thoracic tumours - Anticancer agents & Biologic therapy
14 Apr 2014 A Subset of Breast Cancer Patients Most Likely to Benefit From Neoadjuvant Regimen With Pan-HER Inhibitor Neratinib Breast cancer - Anticancer agents & Biologic therapy
10 Apr 2014 No Prognostic Effect of HPV on the Outcome of Primary Radiotherapy in Advanced Non-Oropharyngeal Cancers Head and neck cancers
08 Apr 2014 Combination of Palbociclib and Letrozole Shows Promising Results in First-Line Treatment of ER-Positive, HER2-Negative Advanced Breast Cancer Breast cancer - Anticancer agents & Biologic therapy
07 Apr 2014 Prognostic and Predictive Value of Rare EGFR Exon 18 and Exon 20 Mutations in Advanced NSCLC Lung and other thoracic tumours
04 Apr 2014 Guides for Patients Now Available in Greek
03 Apr 2014 Genetic Mutations Predispose to Familial Melanoma Pathology/Molecular biology - Melanoma
03 Apr 2014 When to Consider Doxorubicin Alone or in Combination With Ifosfamide for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma? Sarcomas - Anticancer agents & Biologic therapy
02 Apr 2014 Next Generation ALK Inhibitor for ALK-Rearranged Non–Small Cell Lung Cancer Personalised medicine - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
01 Apr 2014 Image of the Month